当前位置:首页 - 行情中心 - 润达医疗(603108) - 财务分析 - 资产负债表

润达医疗

(603108)

  

流通市值:126.03亿  总市值:126.03亿
流通股本:5.97亿   总股本:5.97亿

资产负债表

报告期2023-09-302023-06-302023-03-312022-12-31
公司类型通用通用通用通用
流动资产:
货币资金916,707,199.151,131,737,727.61,082,919,129.261,007,052,275.15
应收票据及应收账款6,031,016,318.496,062,459,064.725,990,950,949.066,013,869,014.2
其中:应收票据118,599,582.0683,166,163.591,481,076.9293,056,685.28
应收账款5,912,416,736.435,979,292,901.225,899,469,872.145,920,812,328.92
应收款项融资2,177,415.094,890,681.424,017,637.31-
预付款项990,068,581.26992,899,753.06933,936,643.66809,408,530.51
其他应收款合计225,666,050.85294,576,370.19239,067,471.46233,382,174.54
应收股利98,68617,783,502.043,000,0003,000,000
存货1,524,290,447.371,417,773,776.421,525,369,711.061,615,932,474.38
一年内到期的非流动资产35,492,072.1332,383,060.8131,307,145.8421,297,936.17
其他流动资产24,046,726.523,019,034.8625,520,810.4711,715,119.92
流动资产平衡项目0000
流动资产合计9,859,464,810.8410,089,639,469.089,958,089,498.129,819,157,524.87
非流动资产:
长期应收款22,052,860.7123,509,333.9525,408,527.2723,119,540.45
长期股权投资1,133,761,667.011,122,806,349.341,125,667,540.111,100,257,337.23
其他权益工具投资41,236,854.5341,352,184.9533,652,184.9528,652,184.95
固定资产932,912,017.86957,518,298.88960,128,908.41962,093,569
在建工程45,732,594.7540,850,176.2634,839,209.9941,433,431.25
使用权资产156,670,116.98154,387,170.89136,627,832.12153,279,307.1
无形资产64,931,288.3174,197,019.3375,403,424.8169,459,189.01
商誉1,986,549,486.941,987,641,407.121,987,641,407.121,987,641,407.12
长期待摊费用104,297,197.53114,043,287.97116,434,837.71118,140,600.47
递延所得税资产205,635,309.59212,023,687.92212,878,163.71203,328,685.49
其他非流动资产11,426,476.2811,684,342.216,849,776.2812,299,564.28
非流动资产平衡项目0000
非流动资产合计4,705,205,870.494,740,013,258.824,715,531,812.484,699,704,816.35
资产平衡项目0000
资产总计14,564,670,681.3314,829,652,727.914,673,621,310.614,518,862,341.22
流动负债:
短期借款4,921,509,782.275,271,168,073.655,447,686,596.285,214,905,648.11
应付票据及应付账款1,658,667,285.231,573,872,064.181,608,869,200.111,836,204,324.57
其中:应付票据125,000,00093,000,000105,400,000151,327,872.49
应付账款1,533,667,285.231,480,872,064.181,503,469,200.111,684,876,452.08
预收款项14,426,420.6918,346,997.0618,892,096.6618,426,203.37
合同负债125,586,357.9127,328,143.05128,876,318.19167,507,327.14
应付职工薪酬63,404,675.9651,548,491.9662,256,554.55108,091,027.88
应交税费97,352,097.01104,238,666.17125,175,094.65143,012,489.01
其他应付款合计216,309,653.79352,888,824.94277,594,695.77281,379,583.29
应付股利20,699,354.497,830,814.4522,899,354.46,899,354.4
一年内到期的非流动负债562,511,449.03766,049,827.37841,613,052.55718,205,901.61
其他流动负债15,686,889.1915,941,391.0515,994,185.5321,057,411.39
流动负债平衡项目0000
流动负债合计7,675,454,611.078,281,382,479.438,526,957,794.298,508,789,916.37
非流动负债:
长期借款622,086,600687,433,800338,068,800337,506,000
应付债券803,040,554.63492,785,502.3492,667,883.93486,070,020.29
租赁负债105,735,068.3104,630,704.3986,937,610.02107,342,328.64
长期应付款46,911,155.166,092,290.884,108,437.4326,108,189.18
预计负债2,217,016.092,271,098.11,304,651.261,619,000.62
递延收益16,250,463.5220,553,673.7622,398,214.1117,918,863.58
递延所得税负债24,118,381.8321,153,657.3115,892,457.4916,626,240.17
其他非流动负债7,780,444.457,535,710.827,359,512.657,031,467.55
非流动负债平衡项目0000
非流动负债合计1,628,139,683.921,402,456,437.481,048,737,566.891,000,222,110.03
负债平衡项目0000
负债合计9,303,594,294.999,683,838,916.919,575,695,361.189,509,012,026.4
所有者权益(或股东权益):
实收资本(或股本)579,641,719579,632,417579,544,726579,543,067
其他权益工具109,926,463.81109,951,111.31110,183,960.09110,188,368.59
资本公积920,632,662.24921,124,429.73921,156,825.01921,060,679.36
其他综合收益5,216,923.983,856,959.278,037,547.687,490,764.13
盈余公积100,248,254.66100,248,254.66100,248,254.66100,248,254.66
未分配利润2,366,390,146.212,257,930,229.292,250,918,643.152,169,882,834.7
归属于母公司股东权益平衡项目0000
归属于母公司股东权益合计4,082,056,169.93,972,743,401.263,970,089,956.593,888,413,968.44
少数股东权益1,179,020,216.441,173,070,409.731,127,835,992.831,121,436,346.38
股东权益平衡项目0000
股东权益合计5,261,076,386.345,145,813,810.995,097,925,949.425,009,850,314.82
负债和股东权益合计14,564,670,681.3314,829,652,727.914,673,621,310.614,518,862,341.22
公告日期2023-10-272023-08-302023-04-272023-04-26
审计意见(境内)标准无保留意见
TOP↑